- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04564807
Testing an Online Insomnia Intervention
October 24, 2022 updated by: Jessica Weafer
The objective of this trial is to determine the effectiveness of an electronic cognitive behavioral therapy for insomnia (e-CBT-I) module in improving sleep and reducing alcohol use among heavy drinkers with insomnia.
Specifically, it will test the effectiveness of Sleep Healthy Using the Internet (SHUTi), a well-validated version of e-CBT-I comprised of 6 weekly educational modules and daily sleep diaries.
The rationale for this mixed methods proposal is that effective, nonpharmacologic treatments are necessary to stem the highly comorbid public health problems of alcohol use disorder (AUD) and insomnia.
If successful, SHUTi will represent a novel and easily accessible intervention for reducing alcohol intake among high-risk heavy drinkers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
71
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kentucky
-
Lexington, Kentucky, United States, 40504
- University Of Kentucky Psychology Research Lab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 50 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- engage in weekly alcohol binge episodes
- moderate to severe insomnia
Exclusion Criteria:
- history of severe alcohol or other substance use disorder
- obstructive sleep apnea
- schizophrenia
- bipolar disorder
- psychotic spectrum disorder
- lack of internet access
- lack of English fluency
- pregnant or nursing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Web-Based Insomnia Education Program
Adult heavy drinkers with insomnia.
|
Participants will be given access to a web-based program on sleep education to read at their own pace during the 9-week intervention period.
The program content overlaps with SHUTi on the following topics: insomnia symptoms, impacts, and causes, basic sleep improvement strategies, and when to see a doctor.
The information is akin to that found on WebMD or National Sleep Foundation website.
Unlike the SHUTi program, the information is fixed, accessible immediately (no week-to-week information "unlocking") and there are no customized bedtime or wake-time suggestions based on sleep diary data.
|
EXPERIMENTAL: SHUTi Intervention
Adult heavy drinkers with insomnia.
|
Sleep Healthy Using the Internet (SHUTi) is a well-validated version of e-CBT-I comprised of 6 weekly educational modules and daily sleep diaries.
Participants will have 9 weeks to complete 6 once-weekly educational "cores."
Cores consist of: insomnia overview, sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, and relapse prevention, and last approximately 45 minutes each.
Participants will receive weekly objectives, as well as review and feedback on the previous core's assignments and sleep diary data, new material, assignments, and a summary.
These features are supplemented with interactive features (i.e., personalized goal-setting, video vignettes).
Participants receive daily emails prompting them to complete the 11-item sleep and alcohol use diary daily during the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Alcohol Use
Time Frame: 12 months (at baseline, 9 weeks, 3 months post-intervention, and 6 months post-intervention)
|
Alcohol use will be measured using the Timeline Follow Back (TLFB) calendar.
Participants will report their drinking over the past 30 days.
|
12 months (at baseline, 9 weeks, 3 months post-intervention, and 6 months post-intervention)
|
Change in Insomnia
Time Frame: 12 months (at baseline, 9 weeks, 3 months post-intervention, and 6 months post-intervention)
|
Insomnia will be measured using the Insomnia Severity Index (ISI).
This survey has 7 questions related to insomnia.
Scores range from 0-28, with higher scores indicating increased insomnia.
|
12 months (at baseline, 9 weeks, 3 months post-intervention, and 6 months post-intervention)
|
Change in Sleep Quality
Time Frame: 12 months (at baseline, 9 weeks, 3 months post-intervention, and 6 months post-intervention)
|
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI).
It measures seven areas (components): subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction.
Scores range from 0-indefinite.
A score greater than 5 is indicative of poor sleep quality.
|
12 months (at baseline, 9 weeks, 3 months post-intervention, and 6 months post-intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 25, 2020
Primary Completion (ACTUAL)
May 31, 2022
Study Completion (ACTUAL)
May 31, 2022
Study Registration Dates
First Submitted
September 22, 2020
First Submitted That Met QC Criteria
September 22, 2020
First Posted (ACTUAL)
September 25, 2020
Study Record Updates
Last Update Posted (ACTUAL)
October 25, 2022
Last Update Submitted That Met QC Criteria
October 24, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 60446
- 1013179870 (OTHER_GRANT: SUPRA)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Leiden UniversityBioClock Consortium; Caring UniveristiesCompleted
-
National Science Council, TaiwanCompleted
-
Sunshine Lake Pharma Co., Ltd.Unknown
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
-
Butler HospitalSunovionCompleted
Clinical Trials on SHUTi Intervention
-
VA Office of Research and DevelopmentVA Connecticut Healthcare System; US Department of Veterans AffairsCompleted
-
University of VirginiaNational Institute of Mental Health (NIMH)CompletedInsomnia | Sleep Initiation and Maintenance DisordersUnited States
-
Indiana UniversityCompletedInsomnia | HIV/AIDSUnited States
-
Kaiser PermanenteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingDiabetes Mellitus, Type 2 | Sleep Initiation and Maintenance Disorders | Prediabetic StateUnited States
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)TerminatedInsomnia | AsthmaUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)RecruitingInsomnia | Sleep | Childhood Cancer | Survivorship | Late Effect | Neurocognitive ImpairmentUnited States
-
University of VirginiaRecruitingNervous System Diseases | Sleep Disorders, Intrinsic | Dyssomnias | Sleep Wake Disorders | Insomnia | Sleep Initiation and Maintenance Disorders | Cognitive Dysfunction | Alzheimer Disease | Mild Cognitive ImpairmentUnited States
-
Indiana UniversityNational Institute of Mental Health (NIMH)Completed
-
Boston UniversityPatient-Centered Outcomes Research InstituteCompleted
-
Jessica WeaferNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingAlcohol Use Disorder | Heavy DrinkingUnited States